Published in Pediatr Transplant on November 01, 2010
Duration of chronic kidney disease reduces attention and executive function in pediatric patients. Kidney Int (2014) 0.87
Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy. Pediatr Nephrol (2013) 0.84
Longitudinal study of cognitive and academic outcomes after pediatric liver transplantation. J Pediatr (2014) 0.82
Geographic determinants of access to pediatric deceased donor kidney transplantation. J Am Soc Nephrol (2014) 0.80
Long-term effects of paediatric kidney transplantation. Nat Rev Nephrol (2015) 0.75
Effect of renal transplantation on cognitive function in hemodialysis patients: a longitudinal study. Int Urol Nephrol (2017) 0.75
Neurocognitive functions of pediatric kidney transplant recipients. Pediatr Nephrol (2016) 0.75
Chronic kidney disease in children: the global perspective. Pediatr Nephrol (2007) 3.05
Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev (2006) 1.36
Cognitive functioning in children on dialysis and post-transplantation. Pediatr Transplant (2000) 1.22
Cognitive functioning and school performance in children with renal failure. Pediatr Nephrol (1994) 1.18
Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol (2006) 1.17
Clinical predictors of neurocognitive deficits in children with chronic kidney disease. Pediatr Nephrol (2006) 1.14
Improvement in specific aspects of neurocognitive performance in children after renal transplantation. Kidney Int (1999) 1.11
The central nervous system in childhood chronic kidney disease. Pediatr Nephrol (2006) 0.99
Neurodevelopmental outcome of children initiating peritoneal dialysis in early infancy. Pediatr Nephrol (1999) 0.94
The cognitive development of pre-school children treated for chronic renal failure. Pediatr Nephrol (1995) 0.89
Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol (2012) 2.83
Association of histologic variants in FSGS clinical trial with presenting features and outcomes. Clin J Am Soc Nephrol (2012) 2.42
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry (2014) 2.15
Hypertension and health outcomes in the PICU. Pediatr Crit Care Med (2014) 1.94
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. J Am Acad Child Adolesc Psychiatry (2012) 1.62
Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol (2006) 1.53
Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics (2010) 1.52
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol (2012) 1.45
Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol (2013) 1.39
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis. Kidney Int (2011) 1.37
Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev (2006) 1.36
Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders. Alcohol Clin Exp Res (2008) 1.29
Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America. Pediatr Nephrol (2006) 1.23
Association between clinical risk factors and progression of chronic kidney disease in children. Clin J Am Soc Nephrol (2010) 1.20
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial. J Child Adolesc Psychopharmacol (2013) 1.19
Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.19
Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med (2014) 1.18
Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol (2006) 1.17
Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol (2009) 1.16
Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci (2004) 1.15
Receptive vocabulary, expressive vocabulary, and speech production of boys with fragile X syndrome in comparison to boys with down syndrome. Am J Ment Retard (2007) 1.14
Problem behavior in boys with fragile X syndrome. Am J Med Genet (2002) 1.13
Neuropsychological findings in childhood neglect and their relationships to pediatric PTSD. J Int Neuropsychol Soc (2009) 1.12
Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Kidney Int (2011) 1.09
A clinical tool to measure the components of health-care transition from pediatric care to adult care: the UNC TR(x)ANSITION scale. Ren Fail (2012) 1.09
Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. Clin J Am Soc Nephrol (2009) 1.09
Demographic, maltreatment, and neurobiological correlates of PTSD symptoms in children and adolescents. J Pediatr Psychol (2009) 1.09
Neurodevelopmental consequences of early traumatic brain injury in 3-year-old children. Pediatrics (2007) 1.07
Blood pressure and school performance. Psychosom Med (2014) 1.06
Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.05
Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group. Am J Kidney Dis (2009) 1.03
Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study. Clin J Am Soc Nephrol (2011) 1.03
Promising insights into the health related quality of life for children with severe obesity. Health Qual Life Outcomes (2013) 1.02
Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. Pediatr Nephrol (2012) 1.02
Memory skills of boys with fragile X syndrome. Am J Ment Retard (2008) 1.00
Cognitive pharmacy services at a pediatric nephrology and hypertension clinic. Ren Fail (2011) 1.00
Visuospatial executive function in Turner syndrome: functional MRI and neurocognitive findings. Brain (2006) 1.00
The central nervous system in childhood chronic kidney disease. Pediatr Nephrol (2006) 0.99
Neurodevelopmental biology associated with childhood sexual abuse. J Child Sex Abus (2011) 0.99
The impact of short stature on health-related quality of life in children with chronic kidney disease. J Pediatr (2013) 0.98
Phase I trial of rosiglitazone in FSGS: I. Report of the FONT Study Group. Clin J Am Soc Nephrol (2008) 0.97
Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes (2013) 0.96
Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes. Am J Hum Genet (2013) 0.96
Gaining the Patient Reported Outcomes Measurement Information System (PROMIS) perspective in chronic kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2014) 0.94
Sensory processing correlates of occupational performance in children with fragile X syndrome: preliminary findings. Am J Occup Ther (2002) 0.94
Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol (2007) 0.93
Brief report: intellectual and academic functioning in pediatric chronic kidney disease. J Pediatr Psychol (2007) 0.93
Discordance in Diagnoses and Treatment of Psychiatric Disorders in Children and Adolescents with 22q11.2 Deletion Syndrome. Asian J Psychiatr (2011) 0.92
Neuropsychological findings in pediatric maltreatment: relationship of PTSD, dissociative symptoms, and abuse/neglect indices to neurocognitive outcomes. Child Maltreat (2013) 0.92
The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2013) 0.90
Implications of different fluid overload definitions in pediatric stem cell transplant patients requiring continuous renal replacement therapy. Intensive Care Med (2012) 0.89
The nervous system and chronic kidney disease in children. Pediatr Nephrol (2004) 0.89
The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis. Am J Kidney Dis (2004) 0.88
Renal transplantation in children with lupus nephritis. Am J Kidney Dis (2003) 0.88
The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation. Child Adolesc Psychiatry Ment Health (2008) 0.88
Hershey Medical Center Technical Workshop Report: optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure. Neurotoxicology (2006) 0.88
Health care transition for adolescents with CKD-the journey from pediatric to adult care. Adv Chronic Kidney Dis (2011) 0.88
PROMIS(®) pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Qual Life Res (2015) 0.87
Unmet dental needs and barriers to dental care among children with autism spectrum disorders. J Autism Dev Disord (2012) 0.86
Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD cohort study. Pediatr Nephrol (2014) 0.86
Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement. Arthritis Care Res (Hoboken) (2013) 0.86
Systematic review of structural and functional neuroimaging findings in children and adults with CKD. Clin J Am Soc Nephrol (2013) 0.85
Socioeconomic status and psychological function in children with chromosome 22q11.2 deletion syndrome: implications for genetic counseling. J Genet Couns (2010) 0.85
Public participation in, and awareness about, medical research opportunities in the era of clinical and translational research. Clin Transl Sci (2013) 0.85
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). Nephron (2015) 0.85
Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group. BMC Nephrol (2010) 0.84
Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder. Drug Alcohol Depend (2013) 0.81
Applicability of the nonverbal learning disability paradigm for children with 22q11.2 deletion syndrome. J Learn Disabil (2012) 0.81
Parent ratings of behavioral functioning after traumatic brain injury in very young children. J Pediatr Psychol (2009) 0.81
Management of toxic ingestions with the use of renal replacement therapy. Pediatr Nephrol (2010) 0.80
Morphometric and neuropsychologic studies in children with arachnoid cysts. Pediatr Neurol (2002) 0.80
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol (2015) 0.79
A multicenter study of neurocognition in children with hypertension: methods, challenges, and solutions. J Am Soc Hypertens (2013) 0.79
Contribution of renal and non-renal clearance on increased total clearance of adalimumab in glomerular disease. J Clin Pharmacol (2013) 0.79
Feasibility and preliminary efficacy data from a computerized cognitive intervention in children with chromosome 22q11.2 deletion syndrome. Res Dev Disabil (2013) 0.79
Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS. Clin J Am Soc Nephrol (2012) 0.79
Neural substrates for processing task-irrelevant emotional distracters in maltreated adolescents with depressive disorders: a pilot study. J Trauma Stress (2012) 0.78
Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry (2012) 0.78
Reading and phonological skills in boys with fragile X syndrome. J Autism Dev Disord (2015) 0.78
Confirmatory factor analysis of the NEPSY for younger and older school-age children. Psychol Rep (2008) 0.78
Regarding Maas's editorial letter on serum suPAR levels. Kidney Int (2012) 0.78
Disordered aldosterone-volume relationship in end-stage kidney disease. J Renin Angiotensin Aldosterone Syst (2009) 0.78
Assessment of parental disclosure of a 22q11.2 deletion syndrome diagnosis and implications for clinicians. J Genet Couns (2012) 0.77
Behavioral risk elicits selective activation of the executive system in adolescents: clinical implications. Front Psychiatry (2011) 0.77
Neurocognitive, Social-Behavioral, and Adaptive Functioning in Preschool Children with Mild to Moderate Kidney Disease. J Dev Behav Pediatr (2016) 0.76
Social-behavioural functioning in paediatric chronic kidney disease. Child Care Health Dev (2009) 0.76
Back to the future: therapies for idiopathic nephrotic syndrome. Blood Purif (2015) 0.76
Three-year course of learning disorders in special education students classified as behavioral disorder. J Am Acad Child Adolesc Psychiatry (2002) 0.76
Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. Eur J Hum Genet (2012) 0.76